What the public record says

The TGA says the Poisons Standard classifies medicines and poisons into schedules reflecting risk and recommended controls. Peptide Checker only marks a compound as scheduled where a primary TGA or government source is attached. Where the public record is a warning, advisory, or adjacent source rather than a schedule entry, the page says that plainly.

What buyers should check

  • Schedule 4 means prescription-only medicine or prescription animal remedy; it is not a retail permission slip.
  • BPC-157 has a source-backed Schedule 4 decision in TGA scheduling material.
  • TGA scheduling material lists CJC-1295, pralmorelin/GHRP-2, GHRP-6, GHRHs, GHRPs, GHSs, hexarelin, ipamorelin, thymosin beta 4, TB-500, and fibroblast growth factors as Schedule 4 and Appendix D Part 5 substances.
  • The TGA's 2026 peptide advisory names BPC-157, GHK-Cu, TB-500, retatrutide, and CJC-1295 as examples of unapproved peptide products, but that advisory is not the same thing as a schedule entry for every named compound.
  • Sport Integrity Australia says somatropin, human growth hormone, is approved by the TGA for prescription medicines. Peptide Checker does not repeat the claim that HGH is Schedule 8 because the source-backed Australian signal found in this pass points to Schedule 4 prescribing control.
  • If a vendor says research use only, that does not remove prescription, advertising, import, or supply questions where the product is a therapeutic good.

Scheduling map

BPC-157Schedule 4 source found

Treat BPC-157 legality claims as prescription-control and unapproved-product questions, not as ordinary supplement language.

TGA BPC-157 final scheduling decision
TB-500 and thymosin beta 4Schedule 4 and Appendix D source found

A seller offering TB-500 should be checked against prescription-only advertising, supply, import, and proof standards.

TGA PIED scheduling material
CJC-1295, Ipamorelin, Hexarelin, GHRP-2, GHRP-6, GHRHs, GHRPs, and GHSsSchedule 4 and Appendix D source found

Growth-hormone pathway peptide claims need prescription and advertising scrutiny before any retail trust is earned.

TGA PIED scheduling material
GHK-CuNamed in TGA unapproved-peptide advisory

Peptide Checker tracks it as a TGA-named unapproved peptide example; a separate schedule-entry source still needs to be attached before schedule language is used.

TGA unapproved peptide products safety advisory
RetatrutideNamed in TGA unapproved-peptide advisory

Retatrutide pages should be read through GLP-1, counterfeit, unapproved-product, and import-risk evidence, not seller purity slogans.

TGA unapproved peptide products safety advisory
Melanotan IISchedule 4 source found in TGA enforcement undertaking

Melanotan II appears in TGA enforcement material as a Schedule 4 prescription-only substance, so public advertising and retail claims deserve extra scrutiny.

TGA Net Pharmacy enforceable undertaking
Human growth hormone / somatropinPrescription medicine source found; Schedule 8 claim not used

Peptide Checker should not call HGH Schedule 8 without a primary schedule source. The source-backed signal in this pass is prescription-medicine control.

Sport Integrity Australia HGH information
MOTS-C, Tesamorelin, IGF-1 LR3, PT-141, DSIP, EpitalonEvidence pending in this map

These belong in the buyer search map, but schedule status should stay pending until a primary Australian source is attached.

TGA Poisons Standard overview

Source links

Use this regulatory brief to ask better supplier questions. Do not convert a market-level warning into a vendor-specific claim unless the vendor page has a source attached.

Open vendor scorecards

Related regulatory briefs